Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Journal of Clinical Investigation

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1172/JCI111703PMID 4038407PMCID PMC423412
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary glomerular diseases (primary glomerulopathies).

  1986cited by this paper
• The metabolism of arachidonic acid by platelets in nephrotic syndrome.

  1984cited by this paper
• Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism.

  1984cited by this paper
• Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.

  1983cited by this paper
• Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.

  1983cited by this paper
• Studies of Prostaglandin Action on the Glomerular Microcirculation

  1983cited by this paper
• Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.

  1983cited by this paper
• In vitro prostaglandin synthesis by human glomeruli and papillae.

  1982cited by this paper
• Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events.

  1982cited by this paper
• Prostaglandin Synthesis by Glomeruli Isolated from Rats with Glycerol‐Induced Acute Renal Failure

  1981cited by this paper
• Exaggerated Prostaglandin and Thromboxane Synthesis in the Rabbit with Renal Vein Constriction

  1980cited by this paper
• Prostaglandin synthesis by isolated rat glomeruli: effect of angiotensin II.

  1980cited by this paper
• Production of thromboxane A2 by the kidney in glycerol-induced acute renal failure in the rabbit.

  1980cited by this paper
• Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man.

  1980cited by this paper
• Delayed hypercoagulability after a single dose of adriamycin to normal rats.

  1979cited by this paper
• Prostaglandin synthesis in isolated glomeruli.

  1979cited by this paper
• Prostaglandin synthesis in isolated rat kidney glomeruli.

  1979cited by this paper
• Immunohistochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex.

  1978cited by this paper
• Renal prostaglandins in renal hypertensive dogs.

  1978cited by this paper
• Release of arachidonic acid from human platelets. A key role for the potentiation of platelet aggregability in normal subjects as well as in those with nephrotic syndrome.

  1978cited by this paper
• Thromboxane A2 biosynthesis in the ureter obstructed isolated perfused kidney of the rabbit.

  1978cited by this paper
• Prostaglandin synthesis in isolated rat glomeruli

  1978cited by this paper
• Increase of free arachidonic acid by furosemide in man as the cause of prostaglandin and renin release.

  1977cited by this paper
• Urinary prostaglandins. Identification and origin.

  1975cited by this paper
• Evolution histologique des glomérulonéphrites prolifératives diffuses tratées par l'indométhacine

  1969cited by this paper
• [Histological course of diffuse proliferative glomerulonephritis treated with indomethacin].

  1969cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• Endogenous Creatinine in Serum and Urine.∗ †

  1950cited by this paper

• Janus kinase inhibitors enhance prostanoid biosynthesis in human whole blood in vitro: implications for cardiovascular side effects and prevention strategies.

  2025cites this paper
• Kidney and urinary tract involvement in systemic mastocytosis.

  2023cites this paper
• Nutritional and nonnutritional management of the nephrotic syndrome

  2022cites this paper
• Thromboxane synthase deficiency improves insulin action and attenuates adipose tissue fibrosis.

  2015cites this paper
• Nutritional and Non-nutritional Management of the Nephrotic Syndrome

  2013cites this paper
• Ratio of urinary potassium to urinary sodium and the potassium and edema status in nephrotic syndrome.

  2011cites this paper
• The EP4 receptor for prostaglandin E2 in glomerular disease: a good receptor turned bad?

  2010cites this paper
• Increased urinary excretion of thromboxane B 2 and 2 , 3-dinor-TxB 2 in cyclosporin A nephrotoxicity

  2010cites this paper
• Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases.

  2009cites this paper
• A case of focal segmental glomerulosclerosis showing improvement i renal function with combined low-density lipoprotein apheresis and pravastatin therapy

  2009cites this paper
• PGE2 Causes Mesangial Cell Hypertrophy and Decreases Expression of Cyclin D3

  2009cites this paper
• Biochemical markers of endothelial dysfunction in pediatric nephrotic syndrome

  2009influential citation
• Chapter 11 – Dietary Modulation of the Inflammatory Response

  2008cites this paper
• CHAPTER 92 – Oxidants in Progressive Kidney Disease

  2008cites this paper
• Effect of omega-3 polyunsaturated fatty acids supplementation on reducing hypertension in chronic renal failure dogs.

  2008cites this paper
• Acute Tubulointerstitial Disease in Rats with Experimental Neph rotic Syndrome

  2007cites this paper
• 15‐Deoxy Δ12,14‐prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator‐activated receptor γ in human erythroleukemia cells

  2005cites this paper
• Different Effect of Cyclosporine A and Mycophenolate Mofetil on Passive Heymann Nephritis in the Rat

  2005cites this paper
• Inhibitory Effects of Ligustrazine, a Modulator of Thromboxane-Prostacycline-Nitric Oxide Balance, on Renal Injury in Rats with Passive Heyman Nephritis

  2004cites this paper
• Proinflammatory cytokines enhance COX-1 gene expression in cultured rat glomerular mesangial cells.

  2004cites this paper
• Role of arachidonic acid metabolites and reactive oxygen species in glomerular immune-inflammatory process

  2004cites this paper
• The localization of thromboxane synthase in normal and pathological human kidney tissue using a monoclonal antibody Tü 300

  2004cites this paper
• Increased Expression of CD54, CD18, MHC Class II Molecules, and Proliferating Cell Nuclear Antigen in Acute Puromycin Aminonucleoside Nephrosis

  2003cites this paper
• Demonstration of Antithrombotic Activity of Glomerular

  2003cites this paper
• COX-2 inhibition potentiates the antiproteinuric effect of enalapril in uninephrectomized SHR.

  2003cites this paper
• Dietary fish oil does not prevent doxorubicin-induced cardiomyopathy in rats.

  2002cites this paper
• Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.

  2002cites this paper
• Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum.

  2002cites this paper
• Effects of dietary lipids on daunomycin-induced nephropathy in mice: Comparison between cod liver oil and soybean oil

  2002cites this paper
• Transcription Suppression of Thromboxane Receptor Gene by Peroxisome Proliferator-activated Receptor-γ via an Interaction with Sp1 in Vascular Smooth Muscle Cells*

  2002cites this paper
• Transcriptional Control of the Human Thromboxane Synthase Genein Vivo and in Vitro *

  2002cites this paper
• Green tea catechin improves microsomal phospholipase A2 activity and the arachidonic acid cascade system in the kidney of diabetic rats.

  2002cites this paper
• Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review.

  2001cites this paper
• Vitamin E improves microsomal phospholipase A2 activity and the arachidonic acid cascade in kidney of diabetic rats.

  2001cites this paper
• n-3 Fatty acids and the inflammatory response — biological background

  2001cites this paper
• RATIONALES FOR TREATING IgA NEPHROPATHIES

  2000cites this paper
• Fatty acids and renal disease.

  2000cites this paper
• Suppression of Rat Thromboxane Synthase Gene Transcription by Peroxisome Proliferator-activated Receptor γ in Macrophages via an Interaction with NRF2*

  2000cites this paper
• Rationales for treating IgA nephropathies.

  2000cites this paper
• Elevated urinary excretion of thromboxane B2 in adults with minimal-change nephrotic syndrome.

  2000cites this paper
• Role of ticlopidine on adriamycin-induced nephropathy.

  1999cites this paper
• Changes in glomerular thromboxane A2 receptor expression and ligand binding following immune injury.

  1999cites this paper
• Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis.

  1999cites this paper
• Hyperlipidemia and renal disease: the use of animal models in understanding pathophysiology and approaches to treatment.

  1999cites this paper
• Urinary prostacyclin metabolites in patients with IgA nephropathy

  1999cites this paper
• Animal models of preeclampsia.

  1999cites this paper
• Captopril reduces the proteinuric effect of human growth hormone in adriamycin nephrosis

  1999cites this paper
• The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin.

  1998cites this paper
• The hemolytic uremic syndrome as a complication of adriamycin nephropathy.

  1998cites this paper
• Treatment of Hyperlipidemia in the Nephrotic Syndrome

  1998cites this paper
• Different Actions of the Cyclooxygenase 2 Selective Inhibitor Flosulide in Rats with Passive Heymann Nephritis

  1998cites this paper
• Changes in platelet calcium concentration by thromboxane A2 stimulation in patients with nephrotic syndrome of childhood.

  1997cites this paper
• Hyperlipidemic nephropathy induced by adriamycin: effect of melatonin administration.

  1997cites this paper
• Expression of thromboxane synthase in kidney tissues from patients with IgA nephropathy.

  1997cites this paper
• Events That Stimulate Release of Thromboxane B2 in Passive Heymann Nephritis

  1997cites this paper
• Rat kidney thromboxane synthase: cDNA cloning and gene expression regulation in hydronephrotic kidney.

  1997cites this paper
• Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs.

  1996cites this paper
• Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside.

  1996cites this paper
• Effect of DP-1904, a thromboxane A2 synthase inhibitor, on passive Heymann nephritis in rats.

  1996cites this paper
• Prevention of acute renal failure.

  1996cites this paper
• Lipid peroxidation and antioxidant defense mechanisms in rat renal tissue after daunorubicin administration.

  1996cites this paper
• Antiproteinuric effect of a thromboxane receptor antagonist, S-1452, on rat diabetic nephropathy and murine lupus nephritis.

  1995cites this paper
• The hyperfiltration theory: progression of chronic renal failure and the effects of diet in dogs.

  1995cites this paper
• The effects of nonsteroidal anti-inflammatory drugs on glomerular filtration of proteins and their therapeutic utility.

  1995cites this paper
• Effect of DP-1904, a thromboxane A2 synthase inhibitor, administered from the autologous phase on crescentic-type anti-GBM nephritis in rats.

  1995cites this paper
• Sistema de coagulação nas glomerulopatias

  1995cites this paper
• Effects of dietary cholesterol on the fatty acid composition of glomerular phospholipids in the rat

  1995cites this paper
• Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization.

  1995cites this paper
• The role of reactive oxygen metabolites in glomerular disease.

  1995cites this paper
• Renal synthesis of prostaglandins and thromboxane has no causative role for protein-induced glomerular hyperfiltration in healthy humans.

  1994cites this paper
• Effect of DP-1904, a thromboxane A2 synthetase inhibitor, on crescentic nephritis in rats.

  1994cites this paper
• Probucol reduces renal injury in the ExHC rat.

  1994cites this paper
• Effect of various drugs on adriamycin-enhanced venous thrombosis in the rat: importance of PAF.

  1994cites this paper
• Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.

  1994cites this paper
• The effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome

  1994cites this paper
• Synergistic Effects of Fish Oil Diet and Dimethylthiourea in Acute Adriamycin Nephrosis

  1994cites this paper
• In vitro modulation of interleukin-1 beta secretion by cultured rat doxorubicin-stimulated whole glomeruli and dissociated mesangial glomerular cells.

  1994cites this paper
• n-3 fatty acids and renal diseases.

  1994cites this paper
• Advances in pharmacology and therapy of nephritides.

  1994cites this paper
• Studies on basement membrane permeation : models of pathogenic mechanims of glomerulonephritis

  1994cites this paper
• Hormonal modulation of proteinuria in the nephrotic syndrome.

  1993cites this paper
• Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome.

  1993cites this paper
• Effects of KW-3635, a specific thromboxane A2-receptor antagonist, on the development of lupus nephritis in NZB x NZW F1 mice.

  1993cites this paper
• Five-to-seven-day kidney preservation with aspirin and furegrelate.

  1993cites this paper
• Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.

  1993cites this paper
• Treatment with a combination of low-density lipoprotein aphaeresis and pravastatin of a patient with drug-resistant nephrotic syndrome due to focal segmental glomerulosclerosis

  1993cites this paper
• In vivo glucuronidation in rat and humans of 5,6-dihydro-7-(1H-imidazol-1-yl)-naphthalene-2-carboxylic acid, a selective inhibitor of thromboxane synthase.

  1993cites this paper
• Renal prostaglandins and thromboxane A2 lack a functional significance in the genesis of protein-induced glomerular hyperfiltration in human renal disease.

  1993cites this paper
• Reduction in urinary prostaglandin excretion in the premenstrual syndrome.

  1993cites this paper
• Fish oil has protective and therapeutic effects on proteinuria in passive Heymann nephritis.

  1993cites this paper
• Effect of L-arginine treatment in pregnant rats with adriamycin nephropathy

  1993cites this paper
• Glomerular thromboxane A2/prostaglandin H2 receptors: characterization and effect of adriamycin-induced nephrotic syndrome.

  1993cites this paper
• n-3 fatty acids reduce proteinuria in patients with chronic glomerular disease.

  1993cites this paper
• Phospholipid derived mediators and glomerulonephritis

  1993cites this paper
• Adriamycin nephropathy: a model to study effects of pregnancy on renal disease in rats.

  1992cites this paper
• Thromboxane in the pathogenesis of glomerular injury in diabetes.

  1992cites this paper
• Enhanced urinary excretion of eicosanoids in fawn-hooded rats.

  1992cites this paper
• Effects of captopril on the development of rat doxorubicin nephropathy.

  1992cites this paper
• Glomerular hemodynamics and eicosanoid synthesis in a rat model of IgA nephropathy.

  1992cites this paper
• Role of glutathione metabolism in the reduction of proteinuria by dimethylthiourea in adriamycin nephrosis.

  1992cites this paper